Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension, January 2019

Free Subscription


Retrieve all available abstracts of the following 201 articles:
HTML format


Single Articles

  1. ZHANG YT, Xue JJ, Wang Q, Cheng SY, et al
    Dehydroepiandrosterone attenuates pulmonary artery and right ventricular remodeling in a rat model of pulmonary hypertension due to left heart failure.
    Life Sci. 2018 Dec 31. pii: S0024-3205(18)30857.
    Abstract     Related articles   

  2. SENGUPTA S, Dey D, Bhattacharyya P
    Correlating between chronic obstructive pulmonary disease assessment test and emPHasis score in Group III pulmonary hypertension patients.
    Lung India. 2019;36:86-87.
    Abstract     Related articles   

  3. SULIMAN HB, Nozik-Grayck E
    Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension.
    Antioxid Redox Signal. 2019 Jan 3. doi: 10.1089/ars.2018.7705.
    Abstract     Related articles   

  4. CHENG CY, Zhang YX, Denas G, Du Y, et al
    Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
    Intern Emerg Med. 2019 Jan 2. pii: 10.1007/s11739-018-02021.
    Abstract     Related articles   

  5. CHEN C, Liu J, Liu Z, He X, et al
    Electrocardiogram signs of right ventricular hypertrophy may help identify pulmonary hypertension in patients with dilated cardiomyopathy.
    Int J Cardiol Heart Vasc. 2018;22:61-66.
    Abstract     Related articles   

  6. LINDHOLM A, Hesselstrand R, Radegran G, Arheden H, et al
    Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
    Clin Physiol Funct Imaging. 2018 Dec 31. doi: 10.1111/cpf.12561.
    Abstract     Related articles   

  7. MIRI M, Hejazi S, Maghsoudlou F, Ahmadi M, et al
    Prevalence of Pulmonary Hypertension in End-stage Renal Disease Patients Undergoing Hemodialysis and Peritoneal Dialysis at a Referral Center in Mashhad, Iran, From 2015 to 2016.
    Iran J Kidney Dis. 2018;12:364-368.
    Abstract     Related articles   

  8. HUA C, Zhao J, Wang H, Chen F, et al
    Apple polyphenol relieves hypoxia-induced pulmonary arterial hypertension via pulmonary endothelium protection and smooth muscle relaxation: In vivo and in vitro studies.
    Biomed Pharmacother. 2018;107:937-944.
    Abstract     Related articles   

  9. POTUS F, Hindmarch CCT, Dunham-Snary KJ, Stafford J, et al
    Transcriptomic Signature of Right Ventricular Failure in Experimental Pulmonary Arterial Hypertension: Deep Sequencing Demonstrates Mitochondrial, Fibrotic, Inflammatory and Angiogenic Abnormalities.
    Int J Mol Sci. 2018;19.
    Abstract     Related articles   

  10. LACHANT DJ, Meoli DF, Haight D, Lyons JA, et al
    Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats.
    Exp Lung Res. 2018;44:51-61.
    Abstract     Related articles   

  11. KANAOKA K, Horii M, Nagato H, Kaneda K, et al
    A giant pulmonary artery aneurysm.
    Eur Heart J Cardiovasc Imaging. 2018;19:236.
    Abstract     Related articles   

  12. MAGON W, Stepniewski J, Miszalski-Jamka T, Urbanczyk-Zawadzka M, et al
    Right Ventricular Epicardial Vascularisation in Patients With Pulmonary Arterial Hypertension.
    Heart Lung Circ. 2018;27:1428-1436.
    Abstract     Related articles   

  13. REHMAN MB, Howard LS, Christiaens LP, Gill D, et al
    Resting right ventricular function is associated with exercise performance in PAH, but not in CTEPH.
    Eur Heart J Cardiovasc Imaging. 2018;19:185-192.
    Abstract     Related articles   

  14. PLOEGSTRA MJ, Brokelman JGM, Roos-Hesselink JW, Douwes JM, et al
    Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up.
    Eur Heart J Cardiovasc Imaging. 2018;19:216-224.
    Abstract     Related articles   

  15. ZHU L, Xiao R, Zhang X, Lang Y, et al
    Spermine on Endothelial Extracellular Vesicles Mediates Smoking-Induced Pulmonary Hypertension Partially Through Calcium-Sensing Receptor.
    Arterioscler Thromb Vasc Biol. 2019 Jan 10:ATVBAHA118312280.
    Abstract     Related articles   

  16. NOORBAKHSH KA, Bell-Cheddar YR, Marin JR
    Focused Cardiac Ultrasound in Pediatric Pulmonary Hypertension.
    Pediatr Emerg Care. 2019 Jan 7. doi: 10.1097/PEC.0000000000001700.
    Abstract     Related articles   

  17. JACOBS ER, Narayanan J, Fish BL, Gao F, et al
    Cardiac Remodeling and Reversible Pulmonary Hypertension During Pneumonitis in Rats after 13-Gy Partial-Body Irradiation with Minimal Bone Marrow Sparing: Effect of Lisinopril.
    Health Phys. 2019 Jan 8. doi: 10.1097/HP.0000000000000919.
    Abstract     Related articles   

  18. HAMATANI Y, Amaki M, Yonezawa R, Yanagi Y, et al
    Prevalence, determinants, and prognostic significance of exercise-induced pulmonary hypertension in patients with hypertrophic cardiomyopathy.
    Int J Cardiovasc Imaging. 2019 Jan 8. pii: 10.1007/s10554-018-01522.
    Abstract     Related articles   

  19. TANG H, Wu K, Wang J, Vinjamuri S, et al
    Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension.
    JACC Basic Transl Sci. 2018;3:744-762.
    Abstract     Related articles   

  20. HE Q, Nan X, Li S, Su S, et al
    Tsantan Sumtang Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Inhibiting Proliferation of Pulmonary Vascular Cells.
    Biomed Res Int. 2018;2018:9504158.
    Abstract     Related articles   

  21. MORADI F, Morris TA, Hoh CK
    Perfusion Scintigraphy in Diagnosis and Management of Thromboembolic Pulmonary Hypertension.
    Radiographics. 2019;39:169-185.
    Abstract     Related articles   

  22. CHEONG HI, Farha S, Park MM, Thomas JD, et al
    Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension.
    Front Cardiovasc Med. 2018;5:180.
    Abstract     Related articles   

  23. VISWANATHAN G, Mamazhakypov A, Schermuly RT, Rajagopal S, et al
    The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension.
    Front Cardiovasc Med. 2018;5:179.
    Abstract     Related articles   

  24. KARMOUTY-QUINTANA H, Guignabert C, Kwapiszewska G, Ormiston ML, et al
    Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction.
    Front Physiol. 2018;9:1777.
    Abstract     Related articles   

  25. HSU S
    Coupling Right Ventricular-Pulmonary Arterial Research to the Pulmonary Hypertension Patient Bedside.
    Circ Heart Fail. 2019;12:e005715.
    Abstract     Related articles   

    Multimodality treatment for chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2018 Dec 29. pii: S0167-5273(18)36195.
    Abstract     Related articles   

  27. WANG J, Tian XT, Peng Z, Li WQ, et al
    HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.
    Vascul Pharmacol. 2019 Jan 2. pii: S1537-1891(18)30358.
    Abstract     Related articles   

  28. THAYER TE, Huang S, Levinson RT, Farber-Eger E, et al
    Unbiased Phenome-wide Association Studies of Red Cell Distribution Width Identifies Key Associations with Pulmonary Hypertension.
    Ann Am Thorac Soc. 2019 Jan 4. doi: 10.1513/AnnalsATS.201809.
    Abstract     Related articles   

  29. LOMBARD FW, Liang Y
    Perioperative Risk Factors for Mitral Valve Surgery: Atrial Fibrillation and Pulmonary Hypertension.
    Semin Cardiothorac Vasc Anesth. 2019 Jan 4:1089253218821694.
    Abstract     Related articles   

  30. YE LF, Fan Y, Shu Q, Lin R, et al
    Management of persistent pulmonary hypertension in newborns with ECMO support: a single center's experience.
    World J Pediatr. 2019 Jan 3. pii: 10.1007/s12519-018-0215.
    Abstract     Related articles   

  31. SEO HS, Lee H
    Assessment of Right Ventricular Function in Pulmonary Hypertension with Multimodality Imaging.
    J Cardiovasc Imaging. 2018;26:189-200.
    Abstract     Related articles   

  32. WEBER U, Schiefer J, Muhlbacher J, Bernardi MH, et al
    High altitude trekking after lung transplantation: a prospective study using lung ultrasound to detect comets tails for interstitial pulmonary edema in lung transplant recipients and healthy volunteers.
    Transpl Int. 2018;31:1245-1253.
    Abstract     Related articles   

  33. JOPPI R, Gerardi C, Bertele' V, Garattini S, et al
    A disease looking for innovative drugs: The case of pulmonary arterial hypertension.
    Eur J Intern Med. 2018;55:47-51.
    Abstract     Related articles   

  34. YU FY, Yang SC, Ji ES
    [The role of adventitia in hypoxic vascular remodeling].
    Sheng Li Xue Bao. 2018;70:211-216.
    Abstract     Related articles   

  35. COONS JC, Miller T
    Extended-release oral treprostinil in the management of pulmonary arterial hypertension: clinical evidence and experience.
    Ther Adv Respir Dis. 2018;12:1753466618766490.
    Abstract     Related articles   

  36. ZAMBRANO BA, McLean NA, Zhao X, Tan JL, et al
    Image-based computational assessment of vascular wall mechanics and hemodynamics in pulmonary arterial hypertension patients.
    J Biomech. 2018;68:84-92.
    Abstract     Related articles   

  37. NEUMANN V, Knies R, Seidinger A, Simon A, et al
    The beta2 agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via alpha adrenoceptor antagonism.
    FASEB J. 2018;32:2519-2530.
    Abstract     Related articles   

  38. YUAN SM
    Pulmonary artery hypertension in childhood: The transforming growth factor-beta superfamily-related genes.
    Pediatr Neonatol. 2018;59:112-119.
    Abstract     Related articles   

  39. DE VECCHIS R, Cesaro A, Ariano C
    Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.
    Minerva Cardioangiol. 2018;66:659-670.
    Abstract     Related articles   

  40. PRINS KW, Rose L, Archer SL, Pritzker M, et al
    Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.
    J Am Heart Assoc. 2019;8:e011464.
    Abstract     Related articles   

  41. AMER R, Elsayed YN, Graham MR, Sikarwar AS, et al
    Effect of vasopressin on a porcine model of persistent pulmonary hypertension of the newborn.
    Pediatr Pulmonol. 2019 Jan 15. doi: 10.1002/ppul.24248.
    Abstract     Related articles   

  42. STYLE CC, Olutoye OO, Belfort MA, Ayres NA, et al
    Fetal endoscopic tracheal occlusion reduces pulmonary hypertension in severe congenital diaphragmatic hernia.
    Ultrasound Obstet Gynecol. 2019 Jan 14. doi: 10.1002/uog.20216.
    Abstract     Related articles   

  43. TRAMMELL AW, Shah AJ, Phillips LS, Hart CM, et al
    EXPRESS: Mortality in U.S. veterans with pulmonary hypertension: a retrospective analysis of survival by subtype and baseline factors.
    Pulm Circ. 2019 Jan 14:2045894019825763. doi: 10.1177/2045894019825763.
    Abstract     Related articles   

  44. NELIN LD, Potenziano JL
    Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response.
    BMC Pediatr. 2019;19:17.
    Abstract     Related articles   

  45. XU SL, Yang J, Zhang CF, Xu SY, et al
    Serum Cardiac Troponin Elevation Predicts Mortality in Patients with Pulmonary Hypertension: A Meta-Analysis of 8 Cohort Studies.
    Clin Respir J. 2019 Jan 13. doi: 10.1111/crj.12991.
    Abstract     Related articles   

  46. GARCIA-LUNAR I, Pereda D, Santiago E, Solanes N, et al
    Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study.
    Basic Res Cardiol. 2019;114:5.
    Abstract     Related articles   

  47. WANG J, Yu M, Xu J, Cheng Y, et al
    Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension.
    J Biomed Sci. 2019;26:6.
    Abstract     Related articles   

  48. JONE PN, Schafer M, Pan Z, Ivy DD, et al
    Right Ventricular-Arterial Coupling Ratio Derived From 3-Dimensional Echocardiography Predicts Outcomes in Pediatric Pulmonary Hypertension.
    Circ Cardiovasc Imaging. 2019;12:e008176.
    Abstract     Related articles   

  49. NUNES JPL, Cunha AC, Meirinhos T, Nunes A, et al
    Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma - A review.
    Autoimmun Rev. 2018;17:1186-1201.
    Abstract     Related articles   

  50. DAI J, Zhou Q, Chen J, Rexius-Hall ML, et al
    Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathway.
    Nat Commun. 2018;9:3850.
    Abstract     Related articles   

  51. BIASIN V, Wygrecka M, Barnthaler T, Jandl K, et al
    Docking of Meprin alpha to Heparan Sulphate Protects the Endothelium from Inflammatory Cell Extravasation.
    Thromb Haemost. 2018;118:1790-1802.
    Abstract     Related articles   

  52. LULIC F, Virag Z, Jakopovic M, Korade I, et al
    Noninvasive determination of the pulmonary artery input impedance.
    Med Hypotheses. 2018;120:7-13.
    Abstract     Related articles   

  53. HAO X, Ma C, Chen S, Dang J, et al
    Reverse the down regulation of miR-92b-3p by hypoxia can suppress the proliferation of pulmonary artery smooth muscle cells by targeting USP28.
    Biochem Biophys Res Commun. 2018;503:3064-3077.
    Abstract     Related articles   

  54. XIONG W, Xu M, Pudasaini B, Guo X, et al
    The influence of anemia on one-year exacerbation rate of patients with COPD-PH.
    BMC Pulm Med. 2018;18:143.
    Abstract     Related articles   

  55. LUO L, Liu Y, Chen D, Chen F, et al
    CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling.
    Biomed Res Int. 2018;2018:3261436.
    Abstract     Related articles   

  56. SAVLA JJ, Levine BD, Sadek HA
    The Effect of Hypoxia on Cardiovascular Disease: Friend or Foe?
    High Alt Med Biol. 2018;19:124-130.
    Abstract     Related articles   

  57. SALDANHA R, Gan M, Shitole A
    Left ventricle-right atrium shunt following mitral valve replacement.
    Asian Cardiovasc Thorac Ann. 2018;26:496-497.
    Abstract     Related articles   

  58. MECOLI CA, Shah AA, Boin F, Wigley FM, et al
    Vascular complications in systemic sclerosis: a prospective cohort study.
    Clin Rheumatol. 2018;37:2429-2437.
    Abstract     Related articles   

  59. GAVILANES F, Piloto B, Fernandes CJC
    Giant pulmonary artery aneurysm in a patient with schistosomiasis-associated pulmonary arterial hypertension.
    J Bras Pneumol. 2018;44:167.
    Abstract     Related articles   

  60. MURATALI UULU K, Cholponbaeva M, Duishobaev M, Toktosunova A, et al
    A Case of Subacute Infantile Mountain Sickness in a Kyrgyz Child.
    High Alt Med Biol. 2018;19:208-210.
    Abstract     Related articles   

  61. BLUM LK, Cao RRL, Sweatt AJ, Bill M, et al
    Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension.
    Eur J Immunol. 2018;48:874-884.
    Abstract     Related articles   

  62. SHI R, Wei Z, Zhu D, Fu N, et al
    Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Pulm Pharmacol Ther. 2018;48:124-135.
    Abstract     Related articles   

  63. GRISSOM CK, Jones BE
    Respiratory Health Benefits and Risks of Living at Moderate Altitude.
    High Alt Med Biol. 2018;19:109-115.
    Abstract     Related articles   

  64. BAI P, Lyu L, Yu T, Zuo C, et al
    Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-beta1 Signaling.
    Arterioscler Thromb Vasc Biol. 2019 Jan 24:ATVBAHA118312254.
    Abstract     Related articles   

  65. UDLAND CJ, Carey WA, Weaver AL, Mara KC, et al
    Birth Size and Gestational Age Specific Outcomes of Inhaled Nitric Oxide Therapy in Preterm Neonates with Clinically Diagnosed Pulmonary Hypertension.
    Am J Perinatol. 2019 Jan 23. doi: 10.1055/s-0039-1677799.
    Abstract     Related articles   

  66. COMEGLIO P, Filippi S, Sarchielli E, Morelli A, et al
    Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model.
    J Endocrinol Invest. 2019 Jan 23. pii: 10.1007/s40618-019-1009.
    Abstract     Related articles   

  67. RAN H, Schneider M, Pistritto AM, Gerges C, et al
    Echocardiographic evaluation of left ventricular filling pressures in patients with pulmonary hypertension.
    Int J Cardiovasc Imaging. 2019 Jan 21. pii: 10.1007/s10554-019-01528.
    Abstract     Related articles   

  68. DARWICHE T, Collum SD, Bi W, Reynolds JO, et al
    Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
    Exp Physiol. 2019 Jan 21. doi: 10.1113/EP087321.
    Abstract     Related articles   

  69. ABE K, Hosokawa K, Tsutsui H
    Traditional screening tool in the era of modern treatment for chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2019 Jan 11. pii: S0167-5273(18)37124.
    Abstract     Related articles   

  70. WATTE G, Mello M, Altmayer S, Hochhegger B, et al
    Switching from sildenafil to riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2019;277:239.
    Abstract     Related articles   

  71. ZUOYOU L, Shiota S, Morio Y, Sugiyama A, et al
    Borderline pulmonary hypertension associated with chronic hypercapnia in chronic pulmonary disease.
    Respir Physiol Neurobiol. 2019 Jan 17. pii: S1569-9048(18)30388.
    Abstract     Related articles   

  72. DE LAZZARI M, Cipriani A, Rizzo S, Famoso G, et al
    Right Ventricular Junctional Late Gadolinium Enhancement Correlates With Outcomes in Pulmonary Hypertension.
    JACC Cardiovasc Imaging. 2019 Jan 9. pii: S1936-878X(18)31089.
    Abstract     Related articles   

  73. LI T, Luo XJ, Wang EL, Li NS, et al
    Magnesium lithospermate B prevents phenotypic transformation of pulmonary arteries in rats with hypoxic pulmonary hypertension through suppression of NADPH oxidase.
    Eur J Pharmacol. 2019 Jan 16. pii: S0014-2999(19)30028.
    Abstract     Related articles   

  74. BAKHSHAYESHKARAM M, Aghahosseini F, Vaezi F, Kahkooei S, et al
    CT-measured pulmonary artery diameter as an independent predictor of pulmonary hypertension in cystic fibrosis.
    Pol J Radiol. 2018;83:e401-e406.
    Abstract     Related articles   

  75. CHOI EK, Shin SH, Kim EK, Kim HS, et al
    Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age.
    BMC Pediatr. 2019;19:26.
    Abstract     Related articles   

  76. KECHAOU I, Boukhris I
    [Senile rheumatoid arthritis associated with rheumatoid lung: a caricatural observation].
    Pan Afr Med J. 2018;30:253.
    Abstract     Related articles   

  77. BASSE I, Fall AL, Seck N, Boiro D, et al
    [Interauricular communications in children: diagnosis and treatment, about 49 cases at the Children?s University Hospital in Dakar].
    Pan Afr Med J. 2018;30:245.
    Abstract     Related articles   

  78. SU H, Xu X, Yan C, Shi Y, et al
    LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension.
    Respir Res. 2018;19:254.
    Abstract     Related articles   

  79. WISUTTHATHUM S, Demougeot C, Totoson P, Adthapanyawanich K, et al
    Eulophia macrobulbon extract relaxes rat isolated pulmonary artery and protects against monocrotaline-induced pulmonary arterial hypertension.
    Phytomedicine. 2018;50:157-165.
    Abstract     Related articles   

  80. FOX CJ, Cornett EM, Hart BM, Kaye AJ, et al
    Pulmonary vasodilators: Latest evidence and outcomes in the perioperative setting.
    Best Pract Res Clin Anaesthesiol. 2018;32:237-250.
    Abstract     Related articles   

  81. MIAO R, Wan J, Liu J, Yuan JX, et al
    Bone Marrow-Derived Endothelial Progenitor Cells Contribute to Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibition of Store-Operated Ca(2+) Channels.
    Biomed Res Int. 2018;2018:4892349.
    Abstract     Related articles   

  82. KUDRYASHOVA TV, Shen Y, Pena A, Cronin E, et al
    Inhibitory Antibodies against Activin A and TGF-beta Reduce Self-Supported, but Not Soluble Factors-Induced Growth of Human Pulmonary Arterial Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2018;19.
    Abstract     Related articles   

  83. YANG YZ, Zhang YF, Yang L, Xu J, et al
    miR760 mediates hypoxia-induced proliferation and apoptosis of human pulmonary artery smooth muscle cells via targeting TLR4.
    Int J Mol Med. 2018;42:2437-2446.
    Abstract     Related articles   

  84. PETERS EL, Comerford D, Vaz FM, van der Laarse WJ, et al
    Meijer and Vloedman's histochemical demonstration of mitochondrial coupling obeys Lambert-Beer's law in the myocardium.
    Histochem Cell Biol. 2019;151:85-90.
    Abstract     Related articles   

  85. HE X, Wang L, Zhu L, Yuan D, et al
    A case-control study of the genetic polymorphism of IL6 and HAPE risk in a Chinese Han population.
    Clin Respir J. 2018;12:2419-2425.
    Abstract     Related articles   

  86. LIU J, Fei L, Huang GQ, Shang XK, et al
    Right ventricle performances with echocardiography and (99m)Tc myocardial perfusion imaging in pulmonary arterial hypertension patients.
    Exp Biol Med (Maywood). 2018;243:754-761.
    Abstract     Related articles   

  87. KEMPNY A, Wort SJ, Dimopoulos K
    Balloon pulmonary angioplasty for chronic thromboembolic disease: aiming for perfection.
    EuroIntervention. 2018;13:1983-1986.
    Abstract     Related articles   

  88. SUN L, Wang Y, Dong Y, Song S, et al
    Assessment of Right Atrium Function in Patients With Systemic Lupus Erythematosus With Different Pulmonary Artery Systolic Pressures by 2-Dimensional Speckle-Tracking Echocardiography.
    J Ultrasound Med. 2018;37:2345-2351.
    Abstract     Related articles   

  89. YU X, Chen X, Zheng XD, Zhang J, et al
    Growth Differentiation Factor 11 Promotes Abnormal Proliferation and Angiogenesis of Pulmonary Artery Endothelial Cells.
    Hypertension. 2018;71:729-741.
    Abstract     Related articles   

  90. GERRINGER JW, Wagner JC, Velez-Rendon D, Valdez-Jasso D, et al
    Lumped-parameter models of the pulmonary vasculature during the progression of pulmonary arterial hypertension.
    Physiol Rep. 2018;6.
    Abstract     Related articles   

  91. AVDEEV SN, Gaynitdinova VV, Tsareva NA, Merzhoeva ZM, et al
    [Natriuretic peptides as markers of development and prognosis of pulmonary hypertension severity in patients with chronic obstructive disease.]
    Klin Lab Diagn. 2018;63:333-337.
    Abstract     Related articles   

  92. MARTYNYUK TV, Nakonechnikov SN, Chazova IY
    New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension.
    Ter Arkh. 2018;90:72-80.
    Abstract     Related articles   

  93. VALIEVA ZS, Taran IN, Martynyuk TV, Chazova IY, et al
    Modern view on the place of riociguat in the treatment of pulmonary hypertension.
    Ter Arkh. 2018;90:55-59.
    Abstract     Related articles   

  94. CHAZOVA IE, Martynyuk TV, Valieva ZS, Nakonechnikov SN, et al
    The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.
    Ter Arkh. 2018;90:101-109.
    Abstract     Related articles   

  95. BARNES H, Brown Z, Burns A, Williams T, et al
    Phosphodiesterase 5 inhibitors for pulmonary hypertension.
    Cochrane Database Syst Rev. 2019;1:CD012621.
    Abstract     Related articles   

  96. VULLAGANTI S, Tibrewala A, Rich J, Pham DT, et al
    EXPRESS: The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension.
    Pulm Circ. 2019 Jan 30:2045894019831222. doi: 10.1177/2045894019831222.
    Abstract     Related articles   

  97. AKAGI S, Ejiri K, Kasahara S, Nakamura K, et al
    EXPRESS: Improvement of Lung Function and Pulmonary Hypertension After Pulmonary Aneurysm Repair: Case Series.
    Pulm Circ. 2019 Jan 30:2045894019831217. doi: 10.1177/2045894019831217.
    Abstract     Related articles   

  98. MEHRA P, Mehta V, Sukhija R, Sinha AK, et al
    Pulmonary hypertension in left heart disease.
    Arch Med Sci. 2019;15:262-273.
    Abstract     Related articles   

  99. KALANTARI KR, Malek H, Amin A, Moosavi J, et al
    Chronic thromboembolic pulmonary hypertension versus fibrosing mediastinitis.
    Anatol J Cardiol. 2019;21:E4-E5.
    Abstract     Related articles   

  100. NILSSON KF, Gustafsson LE
    Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism.
    Pharmacol Res Perspect. 2019;7:e00462.
    Abstract     Related articles   

  101. SMITH ZR, Rangarajan K, Barrow J, Carter D, et al
    Development of best practice recommendations for the safe use of pulmonary hypertension pharmacotherapies using a modified Delphi method.
    Am J Health Syst Pharm. 2019;76:153-165.
    Abstract     Related articles   

  102. HABASH S, Laser KT, Moosmann J, Reif R, et al
    Normal values of the pulmonary artery acceleration time (PAAT) and the right ventricular ejection time (RVET) in children and adolescents and the impact of the PAAT/RVET-index in the assessment of pulmonary hypertension.
    Int J Cardiovasc Imaging. 2019 Jan 28. pii: 10.1007/s10554-019-01540.
    Abstract     Related articles   

  103. MULCHRONE A, Kellihan HB, Forouzan O, Hacker TA, et al
    A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function.
    Front Cardiovasc Med. 2019;5:189.
    Abstract     Related articles   

  104. ARVANITAKI A, Mouratoglou SA, Evangeliou A, Grosomanidis V, et al
    Quality of Life is Related to Haemodynamics in Precapillary Pulmonary Hypertension.
    Heart Lung Circ. 2019 Jan 15. pii: S1443-9506(19)30025.
    Abstract     Related articles   

  105. RACHDI I, Tougorti M, Daoud F, Aydi Z, et al
    Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
    Ann Cardiol Angeiol (Paris). 2019 Jan 23. pii: S0003-3928(18)30201.
    Abstract     Related articles   

  106. YOSHIHISA A, Yokokawa T, Misaka T, Oikawa M, et al
    Soluble neprilysin does not correlate with prognosis in pulmonary hypertension.
    ESC Heart Fail. 2019 Jan 25. doi: 10.1002/ehf2.12404.
    Abstract     Related articles   

  107. GHAEMIAN A, Nabati M, Dabirian M, Shokri M, et al
    Isolated partial right lower lobe pulmonary venous drainage into the right atrium as a cause of pulmonary hypertension in a middle-aged woman.
    J Clin Ultrasound. 2019 Jan 25. doi: 10.1002/jcu.22691.
    Abstract     Related articles   

  108. ZHAO J, Yang M, Wu X, Yang Z, et al
    Effects of paclitaxel intervention on pulmonary vascular remodeling in rats with pulmonary hypertension.
    Exp Ther Med. 2019;17:1163-1170.
    Abstract     Related articles   

  109. AGGARWAL M, Schuettpelz L, Kolodziej J, Grady RM, et al
    Rapid development of pulmonary hypertension during treatment of paediatric cancer.
    Cardiol Young. 2019 Jan 25:1-4. doi: 10.1017/S1047951118002196.
    Abstract     Related articles   

  110. NTILOUDI D, Zanos S, Gatzoulis MA, Karvounis H, et al
    How to evaluate patients with congenital heart disease-related pulmonary arterial hypertension.
    Expert Rev Cardiovasc Ther. 2019;17:11-18.
    Abstract     Related articles   

  111. ASTADICKO I, Dresse MF, Seghaye MC
    [Cardiac complications of sickle cell disease in children].
    Rev Med Liege. 2018;73:550-556.
    Abstract     Related articles   

  112. ZHU G, Zhang W, Liu Y, Wang S, et al
    miR371b5p inhibits endothelial cell apoptosis in monocrotalineinduced pulmonary arterial hypertension via PTEN/PI3K/Akt signaling pathways.
    Mol Med Rep. 2018;18:5489-5501.
    Abstract     Related articles   

  113. CHOI S, Park SI, Lee GD, Kim HR, et al
    The First Living-Donor Lobar Lung Transplantation in Korea: a Case Report.
    J Korean Med Sci. 2018;33:e282.
    Abstract     Related articles   

  114. VORSELAARS VMM, Hosman AE, Westermann CJJ, Snijder RJ, et al
    Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia.
    Int J Mol Sci. 2018;19.
    Abstract     Related articles   

  115. MANAKENG K, Prasertphol P, Phongpao K, Chuncharunee S, et al
    Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent beta-thalassemia/HbE patients with pulmonary arterial hypertension.
    Ann Hematol. 2019;98:281-288.
    Abstract     Related articles   

  116. JOYCE KE, Lucas SJE, Imray CHE, Balanos GM, et al
    Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema.
    Expert Opin Pharmacother. 2018;19:1891-1902.
    Abstract     Related articles   

  117. RIZZI M, Radovanovic D, Santus P, Airoldi A, et al
    Usefulness of six-minute walk test in systemic sclerosis.
    Clin Exp Rheumatol. 2018;36 Suppl 113:161-167.
    Abstract     Related articles   

  118. BACIK P, Poliacikova P, Kaliska G
    Who needs a permanent pacemaker after transcatheter aortic valve implantation?
    Bratisl Lek Listy. 2018;119:560-565.
    Abstract     Related articles   

  119. YUE Y, Zhang Z, Zhang L, Chen S, et al
    miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Cardiovasc Pathol. 2018;37:15-25.
    Abstract     Related articles   

  120. VANDECASTEELE E, Melsens K, De Keyser F, De Pauw M, et al
    A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Clin Exp Rheumatol. 2018;36 Suppl 113:95-101.
    Abstract     Related articles   

  121. CICCO S, Leone P, Racanelli V, Vacca A, et al
    Mucine-1 Is Related to Cell-Mediated Immunoexpression and Blood Pressure in Pulmonary Artery in Pulmonary Arterial Hypertension (PAH): Preliminary Results.
    Adv Exp Med Biol. 2018;1072:275-280.
    Abstract     Related articles   

  122. TELLO K, Axmann J, Ghofrani HA, Naeije R, et al
    Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension.
    Int J Cardiol. 2018;266:229-235.
    Abstract     Related articles   

  123. LEIFER FG, Konicek DM, Chen KJ, Plaunt AJ, et al
    Inhaled Treprostinil-Prodrug Lipid Nanoparticle Formulations Provide Long-Acting Pulmonary Vasodilation.
    Drug Res (Stuttg). 2018;68:605-614.
    Abstract     Related articles   

  124. LUPPINO ASSAD AP, Gavilanes Oleas F, Alves JL Jr, Dos Santos Fernandes CJC, et al
    Survival of connective tissue disease associated pulmonary arterial hypertension.
    Clin Exp Rheumatol. 2018;36 Suppl 113:186.
    Abstract     Related articles   

  125. CHEN F, Wang H, Lai J, Cai S, et al
    3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies.
    Int J Cardiol. 2018;266:236-241.
    Abstract     Related articles   

  126. RUAN HY, Zhang YG, Liu R
    [Acute effects of intravenous fasudil with different dosage on patients with congenital heart defects and severe pulmonary arterial hypertension].
    Zhonghua Yi Xue Za Zhi. 2018;98:678-681.
    Abstract     Related articles   

  127. VIONNET J, Yerly P, Aubert JD, Pascual M, et al
    Management of severe portopulmonary hypertension with dual oral therapy prior to liver transplantation.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002142.
    Abstract     Related articles   

  128. WALIGORA M, Tyrka A, Miszalski-Jamka T, Urbanczyk-Zawadzka M, et al
    Right atrium enlargement predicts clinically significant supraventricular arrhythmia in patients with pulmonary arterial hypertension.
    Heart Lung. 2018;47:237-242.
    Abstract     Related articles   

  129. MICKAEL CS, Graham BB
    The Role of Type 2 Inflammation in Schistosoma-Induced Pulmonary Hypertension.
    Front Immunol. 2019;10:27.
    Abstract     Related articles   

  130. DIMOPOULOS K, Ernst S, McCabe C, Kempny A, et al
    Pulmonary Artery Denervation: A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension?
    JACC Cardiovasc Interv. 2019;12:285-288.
    Abstract     Related articles   

  131. ZHANG H, Zhang J, Chen M, Xie DJ, et al
    Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure: The PADN-5 Study.
    JACC Cardiovasc Interv. 2019;12:274-284.
    Abstract     Related articles   

  132. FORIS V, Brcic L, Douschan P, Kovacs G, et al
    EXPRESS: Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT.
    Pulm Circ. 2019 Feb 7:2045894019832214. doi: 10.1177/2045894019832214.
    Abstract     Related articles   

  133. PRICE LC, Seckl MJ, Dorfmuller P, Wort SJ, et al
    Tumoral pulmonary hypertension.
    Eur Respir Rev. 2019;28.
    Abstract     Related articles   

  134. LIGON RA, Petit CJ
    Working backward: Retrograde balloon angioplasty of atretic arteries in chronic thromboembolic pulmonary hypertension.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28115.
    Abstract     Related articles   

  135. APATEAN D, Rakic B, Brunel-Guitton C, Hendson G, et al
    Congenital lactic acidosis, cerebral cysts and pulmonary hypertension in an infant with FOXRED1 related complex I deficiency.
    Mol Genet Metab Rep. 2019;18:32-38.
    Abstract     Related articles   

  136. ALBANI S, Biondi F, Stolfo D, Lo Giudice F, et al
    Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature.
    J Cardiovasc Med (Hagerstown). 2019 Jan 31. doi: 10.2459/JCM.0000000000000774.
    Abstract     Related articles   

  137. SOHN DW, Park JB, Lee SP, Kim HK, et al
    EXPRESS: Clinical Implication of Right-Sided Augmentation Pressure in Patients with Pulmonary Hypertension.
    Pulm Circ. 2019 Feb 5:2045894019833352. doi: 10.1177/2045894019833352.
    Abstract     Related articles   

  138. HINRICHS L, Horacek M, Neudorf U, Schlosser T, et al
    Diagnostic Work-Up of Pulmonary Hypertension - Think About Shunt Flow! A Case Report.
    Am J Case Rep. 2019;20:154-158.
    Abstract     Related articles   

  139. CAI G, Liu J, Wang M, Su L, et al
    Mutual promotion of FGF21 and PPARgamma attenuates hypoxia-induced pulmonary hypertension.
    Exp Biol Med (Maywood). 2019 Feb 2:1535370219828692.
    Abstract     Related articles   

  140. FAN F, Tian H, Geng J, Deng J, et al
    Mechanism of Beraprost Effects on Pulmonary Hypertension: Contribution of Cross-Binding to PGE2 Receptor 4 and Modulation of O2 Sensitive Voltage-Gated K(+) Channels.
    Front Pharmacol. 2019;9:1518.
    Abstract     Related articles   

  141. BARNIKEL M, Kneidinger N, Klenner F, Waelde A, et al
    EXPRESS: Real-life data on Selexipag for the treatment of Pulmonary Hypertension.
    Pulm Circ. 2019 Feb 4:2045894019832199. doi: 10.1177/2045894019832199.
    Abstract     Related articles   

  142. TRUONG L, Zheng YM, Wang YX
    Mitochondrial Rieske iron-sulfur protein in pulmonary artery smooth muscle: A key primary signaling molecule in pulmonary hypertension.
    Arch Biochem Biophys. 2019 Jan 30. pii: S0003-9861(18)30669.
    Abstract     Related articles   

  143. MAKKER K, Afolayan AJ, Teng RJ, Konduri GG, et al
    Altered hypoxia-inducible factor-1alpha (HIF-1alpha) signaling contributes to impaired angiogenesis in fetal lambs with persistent pulmonary hypertension of the newborn (PPHN).
    Physiol Rep. 2019;7:e13986.
    Abstract     Related articles   

  144. HARDER EM, Fares WH
    Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000 to 2014.
    Respir Med. 2019;147:26-30.
    Abstract     Related articles   

  145. CHERNYAVSKIY AM, Edemskiy AG, Novikova NV, Romanov AB, et al
    Radiofrequency Pulmonary Artery Ablation for Treatment of Residual Pulmonary Hypertension After Pulmonary Endarterectomy.
    Kardiologiia. 2018;58:15-21.
    Abstract     Related articles   

  146. BHYRAVAVAJHALA S, Yerram S, Galla R, Kotapati VSK, et al
    Reliability of Doppler echocardiography in the assessment of high pulmonary vascular resistance in patients with severe pulmonary arterial hypertension.
    Indian Heart J. 2018;70 Suppl 3:S241-S244.
    Abstract     Related articles   

  147. ZHANG XM, Zhuang Q, Yang MH, Wang W, et al
    [Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46:965-971.
    Abstract     Related articles   

  148. CHANG H, Chang CY, Lee HJ, Chou CY, et al
    Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
    Phytomedicine. 2018;51:205-213.
    Abstract     Related articles   

  149. GUERRA G, Perrotta F, Testa G
    Circulating Endothelial Progenitor Cells Biology and Regenerative Medicine in Pulmonary Vascular Diseases.
    Curr Pharm Biotechnol. 2018;19:700-707.
    Abstract     Related articles   

    [Riskstratification in pulmonary arterial hypertension - renders better treatment and prognosis at highly specialised centers].
    Lakartidningen. 2018;115.
    Abstract     Related articles   

  151. SHARMA A, Pandey NN, Kumar S
    Pulmonary capillary haemangiomatosis causing pulmonary arterial hypertension: a clinician's conundrum.
    BMJ Case Rep. 2018;2018.
    Abstract     Related articles   

  152. DUBIN RF
    Application of echocardiographic data in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 May 16. doi: 10.1097/MNH.0000000000000419.
    Abstract     Related articles   

  153. TANAKA T, Eckardt KU
    HIF Activation Against CVD in CKD: Novel Treatment Opportunities.
    Semin Nephrol. 2018;38:267-276.
    Abstract     Related articles   

  154. NOEL ZR
    Safety concerns regarding selexipag in pulmonary arterial hypertension.
    Am J Health Syst Pharm. 2018;75:420.
    Abstract     Related articles   

  155. HAYASAKA I, Cho K, Akimoto T, Ikeda M, et al
    Genetic basis for childhood interstitial lung disease among Japanese infants and children.
    Pediatr Res. 2018;83:477-483.
    Abstract     Related articles   

  156. PUDASAINI B, Yang GL, Yang C, Guo J, et al
    Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.
    BMC Cardiovasc Disord. 2018;18:56.
    Abstract     Related articles   

    [Management of cardiovascular complications in CML patients treated with tyrosine kinase inhibitors].
    Rinsho Ketsueki. 2018;59:13-26.
    Abstract     Related articles   

  158. ZHAO QH, Wu WH, Gong SG, Jiang R, et al
    [Clinical and imaging features of pulmonary veno-occlusive disease and pulmonary capillary hemangioma].
    Zhonghua Jie He He Hu Xi Za Zhi. 2018;41:41-46.
    Abstract     Related articles   

  159. RODRIGUEZ-ALMENDROS N, Toapanta-Yanchapaxi LN, Aguirre Valadez J, Espinola Zavaleta N, et al
    [Portopulmonary hypertension: Updated review].
    Arch Cardiol Mex. 2018;88:25-38.
    Abstract     Related articles   

  160. ZWIJNENBURG RD, Baggen VJM, Witsenburg M, Boersma E, et al
    Risk Factors for Pulmonary Hypertension in Adults After Atrial Septal Defect Closure.
    Am J Cardiol. 2019 Jan 24. pii: S0002-9149(19)30103.
    Abstract     Related articles   

  161. WEISE-CROSS L, Sands MA, Sheak JR, Broughton BRS, et al
    Actin polymerization contributes to enhanced pulmonary vasoconstrictor reactivity after chronic hypoxia.
    Am J Physiol Heart Circ Physiol. 2018;314:H1011-H1021.
    Abstract     Related articles   

  162. DE WIJS-MEIJLER DPM, van Duin RWB, Duncker DJ, Scherrer U, et al
    Structural and functional changes of the pulmonary vasculature after hypoxia exposure in the neonatal period: a new swine model of pulmonary vascular disease.
    Am J Physiol Heart Circ Physiol. 2018;314:H603-H615.
    Abstract     Related articles   

  163. SU J, Logan CC, Hughes AD, Parker KH, et al
    Impact of chronic hypoxia on proximal pulmonary artery wave propagation and mechanical properties in rats.
    Am J Physiol Heart Circ Physiol. 2018;314:H1264-H1278.
    Abstract     Related articles   

  164. RAFIKOV R, McBride ML, Zemskova M, Kurdyukov S, et al
    Am J Physiol Lung Cell Mol Physiol. 2019 Jan 3. doi: 10.1152/ajplung.00393.2018.
    Abstract     Related articles   

  165. ZHANG R, Su H, Ma X, Xu X, et al
    MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2.
    Am J Physiol Lung Cell Mol Physiol. 2019 Jan 10. doi: 10.1152/ajplung.00387.2018
    Abstract     Related articles   

  166. CHAUDHARY KR, Stewart DJ
    Go with the (back) flow: what can retrograde perfusion teach us about arterial remodeling in pulmonary arterial hypertension?
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L797-L798.
    Abstract     Related articles   

  167. YADAV VR, Song T, Mei L, Joseph L, et al
    PLCgamma1-PKCepsilon-IP3R1 signaling plays an important role in hypoxia-induced calcium response in pulmonary artery smooth muscle cells.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L724-L735.
    Abstract     Related articles   

  168. SURESH K, Servinsky L, Jiang H, Bigham Z, et al
    Reactive oxygen species induced Ca(2+) influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L893-L907.
    Abstract     Related articles   

  169. LU Q, Gottlieb E, Rounds S
    Effects of cigarette smoke on pulmonary endothelial cells.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L743-L756.
    Abstract     Related articles   

  170. ZHOU C, Crockett ES, Batten L, McMurtry IF, et al
    Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L835-L845.
    Abstract     Related articles   

  171. YEE M, Cohen ED, Domm W, Porter GA Jr, et al
    Neonatal hyperoxia depletes pulmonary vein cardiomyocytes in adult mice via mitochondrial oxidation.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L846-L859.
    Abstract     Related articles   

  172. SYSOL JR, Chen J, Singla S, Zhao S, et al
    Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L461-L472.
    Abstract     Related articles   

  173. LI HH, Hsu HH, Chang GJ, Chen IC, et al
    Prostanoid EP4 agonist L-902,688 activates PPARgamma and attenuates pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L349-L359.
    Abstract     Related articles   

  174. BLISSENBACH B, Nakas CT, Kronke M, Geiser T, et al
    Hypoxia-induced changes in plasma micro-RNAs correlate with pulmonary artery pressure at high altitude.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L157-L164.
    Abstract     Related articles   

  175. SUZUKI T, Carrier EJ, Talati MH, Rathinasabapathy A, et al
    Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L118-L126.
    Abstract     Related articles   

  176. BARRETO ORTIZ S, Hori D, Nomura Y, Yun X, et al
    Opsin 3 and 4 mediate light-induced pulmonary vasorelaxation that is potentiated by G protein-coupled receptor kinase 2 inhibition.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L93-L106.
    Abstract     Related articles   

  177. BARMAN SA, Li X, Haigh S, Kondrikov D, et al
    Galectin-3 is Expressed in Vascular Smooth Muscle Cells and Promotes Pulmonary Hypertension through changes in Proliferation, Apoptosis and Fibrosis.
    Am J Physiol Lung Cell Mol Physiol. 2019 Feb 6. doi: 10.1152/ajplung.00186.2018.
    Abstract     Related articles   

  178. BEYER C, Huscher D, Ramming A, Bergmann C, et al
    Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.
    Ann Rheum Dis. 2018;77:626-628.
    Abstract     Related articles   

  179. DODSON MW, Allen-Brady K, Brown LM, Elliott CG, et al
    Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families.
    Chest. 2019;155:384-390.
    Abstract     Related articles   

  180. TU L, Castan A, Mallet C, Guyon L, et al
    Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.
    Circ Res. 2019 Jan 14. doi: 10.1161/CIRCRESAHA.118.313356.
    Abstract     Related articles   

  181. BABICHEVA A, Yuan JX
    Endothelial Notch1 in Pulmonary Hypertension.
    Circ Res. 2019;124:176-179.
    Abstract     Related articles   

  182. Correction to: Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
    Circulation. 2019;139:e1.
    Abstract     Related articles   

  183. KOESTENBERGER M, Avian A, Meinel K, Sallmon H, et al
    Author Response to LTE CLC-18-0673 entitled "Diagnostic and Prognostic Value of Echocardiography in Pulmonary Arterial Hypertension".
    Clin Cardiol. 2018 Aug 1. doi: 10.1002/clc.23038.
    Abstract     Related articles   

  184. DANDEL M, Hetzer R
    Diagnostic and Prognostic Value of Echocardiography in Pulmonary Arterial Hypertension.
    Clin Cardiol. 2018 Aug 1. doi: 10.1002/clc.23036.
    Abstract     Related articles   

  185. TOTARO P, Pelenghi S
    Patient-prosthesis mismatch after mitral valve replacement: complex enigma with more than one solution.
    Eur J Cardiothorac Surg. 2018 Apr 19. pii: 4978191. doi: 10.1093.
    Abstract     Related articles   

  186. BOUCLY A, Weatherald J, Humbert M, Sitbon O, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    Abstract     Related articles   

  187. HOEPER MM, Pittrow D, Opitz C, Gibbs JSR, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    Abstract     Related articles   

  188. DACCORD C, Letovanec I, Yerly P, Bloch J, et al
    First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    Abstract     Related articles   

  189. CONDLIFFE R, Kovacs G
    Identifying early pulmonary arterial hypertension in patients with systemic sclerosis.
    Eur Respir J. 2018;51.
    Abstract     Related articles   

  190. NEWNHAM M, South K, Bleda M, Auger WR, et al
    The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01805-2018.
    Abstract     Related articles   

  191. HOEPER MM, Boucly A, Sitbon O
    Age, risk and outcomes in idiopathic pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    Abstract     Related articles   

  192. SKORO-SAJER N, Gerges C, Balint OH, Kohalmi D, et al
    Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension.
    Heart. 2018;104:1195-1199.
    Abstract     Related articles   

  193. ELHASSAN A, Essandoh M
    Inhaled Levosimendan for Pulmonary Hypertension Treatment During Cardiac Surgery: A Novel Application to Avoid Systemic Hypotension.
    J Cardiothorac Vasc Anesth. 2018 Nov 28. pii: S1053-0770(18)31091.
    Abstract     Related articles   

  194. BOISEN ML, Sardesai MP, Kolarczyk L, Rao VK, et al
    The Year in Thoracic Anesthesia: Selected Highlights From 2017.
    J Cardiothorac Vasc Anesth. 2018 Mar 13. pii: S1053-0770(18)30189.
    Abstract     Related articles   

  195. GREAVES SW, Dye L 3rd, Aranda PS, Cain MT, et al
    Perioperative Management of a Large Idiopathic Pulmonary Artery Aneurysm Without Pulmonary Arterial Hypertension.
    J Cardiothorac Vasc Anesth. 2018;32:2402-2408.
    Abstract     Related articles   

  196. RAM E, Sternik L, Klempfner R, Eldar M, et al
    Sildenafil for Pulmonary Hypertension in the Early Postoperative Period After Mitral Valve Surgery.
    J Cardiothorac Vasc Anesth. 2018 Dec 25. pii: S1053-0770(18)31180.
    Abstract     Related articles   

  197. ALTIT G, Bhombal S, Hopper RK, Tacy TA, et al
    Death or resolution: the "natural history" of pulmonary hypertension in bronchopulmonary dysplasia.
    J Perinatol. 2019 Jan 7. pii: 10.1038/s41372-018-0303.
    Abstract     Related articles   

  198. LOISEL F, Provost B, Guihaire J, Boulate D, et al
    Autologous endothelial progenitor cell therapy improves right ventricular function in a model of chronic thromboembolic pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2019;157:655-666.
    Abstract     Related articles   

  199. CHAOUAT A, Cherifi A, Sitbon O, Girerd N, et al
    [Evaluation of cardiac MRI in the follow up assessment of patients with pulmonary arterial hypertension].
    Rev Mal Respir. 2018;35:749-758.
    Abstract     Related articles   

  200. MILARA J, Ballester B, Morell A, Ortiz JL, et al
    JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study.
    Thorax. 2018;73:519-529.
    Abstract     Related articles   

  201. UENO T, Hiwatashi S, Saka R, Yamanaka H, et al
    Pulmonary Arterial Pressure Management Based on Oral Medicine for Pediatric Living Donor Liver Transplant With Portopulmonary Hypertension.
    Transplant Proc. 2018 Mar 15. pii: S0041-1345(18)30401.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.